Fhit Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Fhit monoclonal antibodies for research focused on understanding Fhit protein functions. Fhit Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fhit, or Fragile Histidine Triad protein, is a tumor suppressor that plays a critical role in maintaining genomic stability and regulating apoptosis. Loss of Fhit expression has been associated with various malignancies, making it an important focus in cancer research. Understanding Fhit's molecular mechanisms can reveal new insights into cancer development and progression. Researchers investigating Fhit can explore its interactions with other proteins and its impact on cellular pathways. Advanced research techniques using monoclonal antibodies enable precise detection and analysis of Fhit expression patterns in different tissue types. Studying Fhit's role in cell cycle regulation and DNA damage response pathways provides valuable information about cancer formation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Fhit's role in cancer biology and potential therapeutic applications.